Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A for axillary hidradenitis suppurativa
RBR-4sp5w6Phase 2Not yet recruiting
- Sponsor
- Federal University of São Paulo
- Start
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of botulinum toxin type A in hidradenitis suppurativa (HS) (2 arms), sponsored by Federal University of São Paulo. Planned start Jun 2019; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on RBR-4sp5w6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4sp5w6.